Current position:Home >Product >
2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxopyrimidin-5-yl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid
2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxopyrimidin-5-yl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid(55067-14-6)
- Name: 2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxopyrimidin-5-yl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid
- Synonyms:7-Benzothiazolesulfonicacid, 2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxo-5-pyrimidinyl]azo]phenyl]-6-methyl-(9CI)
- Molecular Formula:C19H13 N7 O5 S2
- Molecular Weight:483.488
- CAS Registry Number:55067-14-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.55067-14-6 7-Benzothiazolesulfonicacid,2-[4-[2-[2-(cyanoamino)-1,4,5,6-tetrahydro-4,6-dioxo-5-pyrimidinyl]diazenyl]phenyl]-6-methyl-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.55067-14-6 2-(p-((2-(Cyanoimino)hexahydro-4,6-dioxo-5-pyrimidinyl)azo)phenyl)-6-methyl-7-benzothiazolesulfonic acid, triethanolamine salt (1:X)
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.55067-14-6 7-Benzothiazolesulfonicacid,2-[4-[2-[2-(cyanoamino)-1,4,5,6-tetrahydro-4,6-dioxo-5-pyrimidinyl]diazenyl]phenyl]-6-methyl-
Assay:99% Appearance:liquid or powder Package:according to the clients requirement Storage:Dry and Cool Place Transportation:UPS FedEx ,DHL,EXPRESS LINE Application:API
Min. Order:1Gram
Supplier:Shandong Mopai Biotechnology Co., LTD [
China (Mainland)]
Other Product
- 112444-78-7/hemoglobin J Auckland
- 124187-05-9/5-Oxa-3,7-dithia-4,6-digermanonane-1,9-diamine,2,8-dimethyl-, 4,6-dioxide, hydrochloride (1:2)
- 16956-54-0/ethyl (2E)-3-[bis(2-chloroethyl)amino]-2-cyanoprop-2-enoate
- 174393-13-6/L-Glutamic acid,4-(4,4-diphenylbutyl)-, (4S)-
- 5605-90-3/4-[5-(4-fluorophenyl)-1,3-oxazol-2-yl]-1-methylpyridinium benzenesulfonate
- 106555-98-0/boron hydride - N,N-dimethyloctadecan-1-amine (1:3:1)
- 1112-27-2/ethyl 2,4-dicyano-2-(2-cyanoethyl)butanoate
- 226250-05-1/ethyl 4-[(8-hydroxy-5,5-dimethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethynyl]benzoate
- 61790-56-5/Polyphosphoric acids, decyl esters, compds. with triethanolamine
- 24755-74-6/5-allyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol
- 68002-32-4/2-Propenoic acid, polymer with ethenylbenzene, 2-ethylhexyl 2-propenoate, formaldehyde and 2-propenamide, butylated
- 9041-25-2/Hemoglobin G
- 71022-99-6/3-hydroxy-3,3-diphenylpropanethioic S-acid
- 5012-52-2/5,5,5-trichloropent-2-en-1-yl butylcarbamate
- 66346-05-2/1H-1,2,4-Triazole-1-ethanol,b-[(4-chlorophenyl)methyl]-a-(1,1-dimethylethyl)-, (aS,bS)-
- 7247-21-4/2-Pentanone,4,4'-[(1-methyl-1,2-ethanediyl)dinitrilo]bis[1,1,1-trifluoro- (9CI)
- 94550-19-3/Cinnamic acid, a,a'-dithiobis[o-methoxy- (7CI)
- 65060-95-9/normorphine-6-glucuronide
- 5080-61-5/1,1':4',1'':2'',1''':2''',1'''':4'''',1'''''-Sexiphenyl(7CI,8CI,9CI)
- 55067-14-6/2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxopyrimidin-5-yl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid
- 36762-16-0/9-(2-chlorophenyl)acridine
- 25662-14-0/methyl 1-tert-butylaziridine-2-carboxylate
- 32620-61-4/N-(2-FURYLMETHYL)MALEIMIDE
- 101302-80-1/6-[2-(4-methylphenyl)ethyl][1,3,4]thiadiazolo[3,2-a][1,2,3]triazolo[4,5-d]pyrimidin-9(2H)-one
- 85338-20-1/Formaldehyde, reaction products with 2,6-bis(1,1-dimethylethyl)phenol and 4-(1,1,3,3-tetramethylbutyl)-N-(4-(1,1,3,3-tetramethylbutyl)phenyl)benzenamine
- 90452-76-9/Prefondo RL (9CI)
- 4104-12-5/N,N'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[3-oxobutyramide]
- 107494-20-2/L-Leucinamide,N,N-dimethyl-L-phenylalanyl-(3R)-3-(4-formylphenoxy)-L-leucyl- (9CI)
- 14902-80-8/Triphosphoric(III,V,V)acid (7CI,9CI)
- 15866-64-5/1,2-dichloro-4-[4-(3-nitrophenyl)buta-1,3-dien-1-yl]benzene